RUN vs STRO
Sunrun Inc (RUN) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the RUN and STRO stock pages for the full models.
Not investment advice.